Epicor Celebrates 30 Years of Driving Innovation and Customer Success Across Asia at Annual Asia Connect Event
BANGKOK–(BUSINESS WIRE)–Epicor, a global industry-specific enterprise software leader, celebrated a multitude of successes at the company’s annual... Read more.
Patient Square Capital, a Leading Health Care-Focused Investment Firm, Agrees to Acquire NanoString Technologies
Binding Agreement to Acquire Substantially All NanoString Assets for $220 Million Pending Bankruptcy Court Approval Agreement Represents Major Step in Financial... Read more.
Timber Pharmaceuticals, Inc., a LEO Pharma Company, Presents Late-Breaking Preliminary Results of TMB-001 in Moderate-to-Severe Congenital Ichthyosis (CI) at the 2024 AAD Annual Meeting
The late-breaking session at the American Academy of Dermatology (AAD) Annual Meeting offers a first look at data from 17 adult and adolescent participants (aged... Read more.
Incyte Presents New Late-Breaking Data from Phase 2 Study Evaluating Povorcitinib in Patients with Prurigo Nodularis
Randomized Phase 2 study met its primary and secondary endpoints following 16 weeks of treatment across all dosing groups, reinforcing povorcitinib’s potential... Read more.
Incyte Announces New Data from Phase 2 Study Evaluating Ruxolitinib Cream (Opzelura®) in Patients with Mild-to-Moderate Hidradenitis Suppurativa
Randomized Phase 2 study met the primary endpoint in patents with hidradenitis suppurativa (HS), reinforcing efficacy and safety profile of ruxolitinib cream Results... Read more.
Galderma @ AAD 2024: New Data Demonstrate the Long-Term Efficacy of Nemolizumab in Prurigo Nodularis and Its Durability in Atopic Dermatitis
Nemolizumab is a first-in-class investigational monoclonal antibody designed to provide relief from itch by targeting IL-31 One-year data from an interim analysis... Read more.
Illumination and Nintendo Announce New Animated Film Based on the World of Super Mario Bros.
SANTA MONICA, Calif. & KYOTO, Japan–(BUSINESS WIRE)–Illumination (HQ: Santa Monica, CA, USA; Founder and CEO: Chris Meledandri) and Nintendo Co.,... Read more.
LEO Pharma Unveils Late-Breaking Data for Landmark DELTA 3 Open-Label Extension Trial at the 2024 AAD Annual Meeting
Continuing the momentum for LEO Pharma at the ongoing American Academy of Dermatology (AAD) Annual Meeting, a late-breaker presentation shared positive results from... Read more.
MBLY Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Mobileye Global Inc. (MBLY) Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit
RADNOR, Pa.–(BUSINESS WIRE)–#classaction–The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities... Read more.
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on March 8, 2024, the Compensation Committee of Mirum’s... Read more.